Photo Release -- Merrion Announces License Agreement With Novo ... FOXBusiness - Orazol (MER 101) is an oral bisphosphonate for oncology indications currently in Phase II development. This product aims to allow cancer patients with bone ... |
« Akorn-Strides, LLC Announces FDA Approvals for Sterile Vancomycin ... - PR-Inside.com (Pressemitteilung) | Main | ECO Animal Health makes headway in Japanese market - SmallCapNews.co.uk »
TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00e54ed2f1208833010536fe295e970b
Listed below are links to weblogs that reference Photo Release -- Merrion Announces License Agreement With Novo ... - FOXBusiness:
This is only a preview. Your comment has not yet been posted.
As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.
Having trouble reading this image? View an alternate.
Comments